Opportunity Information: Apply for PAR 19 302
The NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required), funding opportunity number PAR-19-302, is a discretionary grant program from the National Institutes of Health (NIH) through the National Institute on Aging (NIA). It supports the implementation of investigator-initiated, multi-site interventional clinical trials across any trial phase, meaning applicants can propose everything from early-stage clinical testing through later-phase effectiveness work as long as the project fits NIA's scientific priorities. The central emphasis is on trials that are hypothesis-driven, with clearly articulated scientific questions and outcomes, and that are milestone-defined, meaning the study is expected to include concrete, measurable progress points that guide trial execution and allow for accountability during the life of the award. In practical terms, this FOA is focused on actually running the clinical trial (implementation) rather than only planning, preliminary feasibility exploration, or purely observational work.
Projects submitted under this announcement are expected to align with NIA's research mission, which broadly covers aging-related science and health, including conditions and challenges that disproportionately affect older adults and aging populations. Because the FOA is explicitly for multi-site interventional trials, applications generally need to demonstrate the ability to coordinate research activities across multiple locations, maintain consistent protocols and data quality, and manage operational issues like recruitment, retention, intervention delivery, and standardized outcome assessment across sites. The "clinical trial required" designation signals that the proposed work must meet NIH's definition of a clinical trial and include an intervention with prospective assignment to study conditions, along with outcomes that evaluate effects on biomedical or behavioral endpoints.
Eligibility is broad and includes many types of U.S. organizations and governmental entities. Eligible applicants include state governments, county governments, city or township governments, special district governments, and independent school districts, as well as public and state-controlled institutions of higher education and private institutions of higher education. Tribal eligibility includes federally recognized Native American tribal governments and Native American tribal organizations that are not federally recognized tribal governments, along with public housing authorities and Indian housing authorities. The opportunity is also open to nonprofit organizations, whether they have 501(c)(3) status or not (as long as they are not institutions of higher education in that category), and to for-profit organizations (other than small businesses) as well as small businesses. Beyond these standard categories, the FOA explicitly calls out additional eligible applicant groups such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). This wide eligibility reflects an intent to support diverse research settings and populations, which can be especially important for multi-site trials seeking representative enrollment.
Administratively, the program is offered as an R01 grant mechanism, which is typically used for substantial, investigator-initiated research projects and, in this case, is specifically tailored to the operational and scientific demands of a multi-site clinical trial. The funding activity category is Health, and the CFDA number listed is 93.866. The opportunity record indicates it was created on 2019-06-24, and it lists an original closing date of 2022-09-07 (noting that actual submission windows and reissues can vary over time, so applicants generally need to confirm current status and dates in the active NIH posting). The award ceiling and expected number of awards are not specified in the provided source data, which often means applicants should look to the full FOA and NIH budget guidance for limits, expectations, and any institute-specific budget considerations.
Overall, this FOA is designed for research teams ready to carry out a rigorously designed, multi-site intervention study with clear hypotheses, defined milestones, and strong operational plans, all tied directly to aging-related research priorities under NIA. It is particularly relevant for investigators who already have the scientific rationale and trial infrastructure readiness to move into full implementation and who can demonstrate the leadership, coordination, and site management capacity needed to execute a complex clinical trial across multiple locations.Apply for PAR 19 302
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2019-06-24.
- Applicants must submit their applications by 2022-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
Previous opportunity: HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 19 302
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 19 302) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) Apply for PAR 19 301 Funding Number: PAR 19 301 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) Apply for RFA AG 20 018 Funding Number: RFA AG 20 018 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Implementation Research on Hypertension Control to Prevent Dementia and Cognitive Decline (R61/R33 Clinical Trial Optional) Apply for RFA AG 20 028 Funding Number: RFA AG 20 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) Apply for PAR 19 304 Funding Number: PAR 19 304 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) Apply for PAR 19 305 Funding Number: PAR 19 305 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 042 Funding Number: RFA AG 20 042 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (R01 Clinical Trial Not Allowed) Apply for RFA MH 20 300 Funding Number: RFA MH 20 300 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Child Neurologist Career Development Program (CNCDP) (K12 Clinical Trial Not Allowed) Apply for RFA NS 19 040 Funding Number: RFA NS 19 040 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed) Apply for PAR 19 307 Funding Number: PAR 19 307 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed) Apply for RFA AG 20 020 Funding Number: RFA AG 20 020 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Transition to Aging Research for Predoctoral Students (F99/K00) Apply for RFA AG 20 009 Funding Number: RFA AG 20 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA AG 20 021 Funding Number: RFA AG 20 021 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD) (R01 Clinical Trial Not Allowed) Apply for RFA NS 20 004 Funding Number: RFA NS 20 004 Agency: National Institutes of Health Category: Health Funding Amount: $499,000 |
| Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) Apply for PAR 19 312 Funding Number: PAR 19 312 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 19 315 Funding Number: PAR 19 315 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 19 011 Funding Number: RFA RM 19 011 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Mechanisms of Tolerance (R21/R33 - Clinical Trial Required) Apply for PAR 19 311 Funding Number: PAR 19 311 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) Apply for PAR 19 313 Funding Number: PAR 19 313 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Specialized Alcohol Research Centers (P50 Clinical trial Optional) Apply for RFA AA 20 001 Funding Number: RFA AA 20 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,150,000 |
| Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional) Apply for RFA AA 20 002 Funding Number: RFA AA 20 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 302", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
